What is Prestige Consumer Healthcare EBIT per Share?
Prestige Consumer Healthcare's EBIT per Share for the
three
months ended in Dec. 2023 was $1.72.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.44.
During the past 12 months, the average EBIT per Share Growth Rate of Prestige Consumer Healthcare was 4.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 7.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 18.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 5.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Prestige Consumer Healthcare's EBIT per Share or its related term are showing as below:
PBH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36.2 Med: 9.85 Max: 82.1
Current: 7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Prestige Consumer Healthcare was 82.10% per year. The lowest was -36.20% per year. And the median was 9.85% per year.
PBH's 3-Year EBIT Growth Rate is ranked worse than 52% of 852
companies
in the Drug Manufacturers industry
Industry Median: 7.95
vs PBH: 7.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prestige Consumer Healthcare (NYSE:PBH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Prestige Consumer Healthcare EBIT per Share Related Terms
Thank you for viewing the detailed overview of Prestige Consumer Healthcare's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Prestige Consumer Healthcare (Prestige Consumer Healthcare) Business Description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBH has been successfully added to your 